We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Gossamer Bio Seeks $230M IPO Amid Government Shutdown

Law360 (January 23, 2019, 9:20 PM EST) -- Biotechnology firm Gossamer Bio Inc. on Wednesday disclosed pricing details for a $230 million initial public offering, using an unconventional route that allows companies to go public without the usual green...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.